Oligonucleotides, Antisense

dystrophin ; Homo sapiens







27 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34698059 Renadirsen, a Novel 2'OMeRNA/ENA® Chimera Antisense Oligonucleotide, Induces Robust Exon 45 Skipping for Dystrophin In Vivo. 2021 Sep 25 1
2 30972156 Antisense oligonucleotides for the treatment of cardiomyopathy in Duchenne muscular dystrophy. 2019 1
3 29067660 Exon Skipping Therapy Using Phosphorodiamidate Morpholino Oligomers in the mdx52 Mouse Model of Duchenne Muscular Dystrophy. 2018 1
4 30171552 Systemic Intravenous Administration of Antisense Therapeutics for Combinatorial Dystrophin and Myostatin Exon Splice Modulation. 2018 1
5 28208626 2'-O-Methyl RNA/Ethylene-Bridged Nucleic Acid Chimera Antisense Oligonucleotides to Induce Dystrophin Exon 45 Skipping. 2017 Feb 10 2
6 27398133 Recent advances in innovative therapeutic approaches for Duchenne muscular dystrophy: from discovery to clinical trials. 2016 1
7 25791417 Phosphorothioate modification of chimeric 2´-O-methyl RNA/ethylene-bridged nucleic acid oligonucleotides increases dystrophin exon 45 skipping capability and reduces cytotoxicity. 2015 Feb 17 2
8 24380394 Skipping multiple exons of dystrophin transcripts using cocktail antisense oligonucleotides. 2014 Feb 1
9 22274137 Novel cationic carotenoid lipids as delivery vectors of antisense oligonucleotides for exon skipping in Duchenne muscular dystrophy. 2012 Jan 24 1
10 22454059 Optimizing RNA/ENA chimeric antisense oligonucleotides using in vitro splicing. 2012 1
11 22454060 Optimizing antisense oligonucleotides using phosphorodiamidate morpholino oligomers. 2012 1
12 22486275 A prospective study in the rational design of efficient antisense oligonucleotides for exon skipping in the DMD gene. 2012 Jul 1
13 21967521 Antisense oligonucleotide induced dystrophin exon 45 skipping at a low half-maximal effective concentration in a cell-free splicing system. 2011 Oct 1
14 20068555 Optimization of peptide nucleic acid antisense oligonucleotides for local and systemic dystrophin splice correction in the mdx mouse. 2010 Apr 1
15 20079639 Comparative analysis of antisense oligonucleotide sequences targeting exon 53 of the human DMD gene: Implications for future clinical trials. 2010 Feb 3
16 20424011 Toward an oligonucleotide therapy for Duchenne muscular dystrophy: a complex development challenge. 2010 Mar 31 1
17 19142179 Design of phosphorodiamidate morpholino oligomers (PMOs) for the induction of exon skipping of the human DMD gene. 2009 Mar 1
18 19351396 Formulation of polylactide-co-glycolic acid nanospheres for encapsulation and sustained release of poly(ethylene imine)-poly(ethylene glycol) copolymers complexed to oligonucleotides. 2009 Apr 7 1
19 19760747 Exon skipping-mediated dystrophin reading frame restoration for small mutations. 2009 Nov 1
20 18784278 Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function. 2008 Dec 15 1
21 17285139 Antisense oligonucleotide-induced exon skipping across the human dystrophin gene transcript. 2007 Jul 2
22 17601349 Antisense oligonucleotide induced exon skipping and the dystrophin gene transcript: cocktails and chemistries. 2007 Jul 2 2
23 17767400 Comparative analysis of antisense oligonucleotide sequences for targeted skipping of exon 51 during dystrophin pre-mRNA splicing in human muscle. 2007 Sep 1
24 16919955 Induced dystrophin exon skipping in human muscle explants. 2006 Oct 1
25 15536518 Antisense oligonucleotides and short interfering RNAs silencing the cyclin-dependent kinase inhibitor p21 improve proliferation of Duchenne muscular dystrophy patients' primary skeletal myoblasts. 2005 Jan 1
26 16259564 Poly(ethylene imine)-poly(ethylene glycol) copolymers facilitate efficient delivery of antisense oligonucleotides to nuclei of mature muscle cells of mdx mice. 2005 Nov 1
27 14527677 Enhanced in vivo delivery of antisense oligonucleotides to restore dystrophin expression in adult mdx mouse muscle. 2003 Sep 25 1